Maarten R. Hillen

775 citations

27 papers · 434 indexed · h-index 14

Co-authors: Aike A. Kruize Joël A. G. van Roon Timothy R. D. J. Radstake Sofie L. M. Blokland Aridaman Pandit J.A. van Roon Francesca Barone Ana P. Lopes
Topics: Salivary Gland Disorders and Functions (22 papers)Systemic Lupus Erythematosus Research (5 papers)Dermatology and Skin Diseases (4 papers)
Cited by: Physiology Immunology Rheumatology
Journals: PLoS ONE Frontiers in Immunology Annals of the Rheumatic Diseases
Partner nations: Netherlands Italy United States

In The Last Decade

Maarten R. Hillen

27 papers receiving 429 citations

Peers

Countries citing papers authored by Maarten R. Hillen

Since Specialization

Citations

This map shows the geographic impact of Maarten R. Hillen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten R. Hillen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten R. Hillen more than expected).

Fields of papers citing papers by Maarten R. Hillen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten R. Hillen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten R. Hillen. The network helps show where Maarten R. Hillen may publish in the future.

Co-authorship network of co-authors of Maarten R. Hillen

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten R. Hillen. A scholar is included among the top collaborators of Maarten R. Hillen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten R. Hillen. Maarten R. Hillen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response 2023 ·RMD Open ·(unknown),(unknown),Ana P. Lopes,Sofie L. M. Blokland,Cornelis P. J. Bekker,Cornelia G van Helden-Meeuwsen,Marjan A. Versnel,Aike A. Kruize,Timothy R. D. J. Radstake,Helen L. Leavis,Maarten R. Hillen,J.A. van Roon	5
2	Deciphering the role of cDC2s in Sjögren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity 2022 ·Annals of the Rheumatic Diseases ·Ana P. Lopes,Maarten R. Hillen,(unknown),Sofie L. M. Blokland,Cornelis P. J. Bekker,Aridaman Pandit,Aike A. Kruize,Timothy R. D. J. Radstake,J.A. van Roon	13
3	The Transcriptomic Profile of Monocytes from Patients With Sjögren’s Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators 2021 ·Frontiers in Immunology ·Ana P. Lopes,Cornelis P. J. Bekker,Maarten R. Hillen,Sofie L. M. Blokland,(unknown),Aridaman Pandit,Aike A. Kruize,Timothy R. D. J. Radstake,Joël A. G. van Roon	19
4	Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial 2020 ·The Lancet Rheumatology ·(unknown),(unknown),Maarten R. Hillen,Ana P. Lopes,(unknown),Antoine J.W.P. Rosenberg,Nard G. Janssen,(unknown),Valentina Iannizzotto,Weiyang Tao,Aridaman Pandit,Francesca Barone,Aike A. Kruize,(unknown),Joël A. G. van Roon	45
5	MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1 2019 ·Frontiers in Immunology ·Ana P. Lopes,Joël A. G. van Roon,Sofie L. M. Blokland,Maojie Wang,Eleni Chouri,Sarita A. Y. Hartgring,(unknown),Aike A. Kruize,Boudewijn Burgering,Marzia Rossato,Timothy R. D. J. Radstake,Maarten R. Hillen	15
6	Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren’s syndrome and non-autoimmune sicca 2019 ·RMD Open ·Sofie L. M. Blokland,Maarten R. Hillen,(unknown),A. Bikker,Wilco de Jager,Aridaman Pandit,Aike A. Kruize,Timothy R. D. J. Radstake,Joël A. G. van Roon	18
7	Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production 2019 ·Frontiers in Immunology ·Maarten R. Hillen,Aridaman Pandit,Sofie L. M. Blokland,Sarita A. Y. Hartgring,Cornelis P. J. Bekker,(unknown),Nila H. Servaas,Marzia Rossato,Aike A. Kruize,Joël A. G. van Roon,Timothy R. D. J. Radstake	47
8	Dysregulated miRNome of plasmacytoid dendritic cells from patients with Sjögren’s syndrome is associated with processes at the centre of their function 2019 ·Lara D. Veeken ·Maarten R. Hillen,Eleni Chouri,Maojie Wang,Sofie L. M. Blokland,Sarita A. Y. Hartgring,(unknown),Aike A. Kruize,Boudewijn Burgering,Marzia Rossato,Joël A. G. van Roon,Timothy R. D. J. Radstake	15
9	THU0222 PLASMACYTOID DCS FROM PATIENTS WITH SJÖGREN'S SYNDROME ARE TRANSCRIPTIONALLY PRIMED FOR ENHANCED PRO-INFLAMMATORY CYTOKINE PRODUCTION 2019 ·Annals of the Rheumatic Diseases ·Maarten R. Hillen,Aridaman Pandit,Sofie L. M. Blokland,Sarita A. Y. Hartgring,Cornelis P. J. Bekker,(unknown),Nila H. Servaas,Marzia Rossato,Aike A. Kruize,Joël van Roon,Timothy R. D. J. Radstake	1
10	THU0238 CLINICAL EFFICACY OF LEFLUNOMIDE/HYDROXYCHLOROQUINE COMBINATION THERAPY IN PRIMARY SJOGREN'S SYNDROME IS PREDICTED BY SERUM PROTEOME BIOMARKERS – RESULTS FROM REPURPSS-I 2019 ·Annals of the Rheumatic Diseases ·Joël van Roon,(unknown),Sofie L. M. Blokland,(unknown),(unknown),Paco M J Welsing,Nard G. Janssen,(unknown),Aridaman Pandit,Weiyang Tao,Maarten R. Hillen,Aike A. Kruize,Timothy R. D. J. Radstake	2
11	Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren’s syndrome 2018 ·PLoS ONE ·Ana P. Lopes,Maarten R. Hillen,Eleni Chouri,Sofie L. M. Blokland,Cornelis P. J. Bekker,Aike A. Kruize,Marzia Rossato,Joël A. G. van Roon,Timothy R. D. J. Radstake	20
12	THU0223 Elevated MTORC1 signature in B cells from sjÖgren's syndrome patients correlates with B cell hyperactivity that is abrogated by MTOR inhibition: a novel therapeutic strategy to halt B cell hyperactivity in PSS? 2017 ·Annals of the Rheumatic Diseases ·(unknown),Maarten R. Hillen,(unknown),(unknown),(unknown),(unknown),(unknown)	2
13	Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis 2017 ·Arthritis & Rheumatology ·Sofie L. M. Blokland,Maarten R. Hillen,Aike A. Kruize,Stephan Meller,Bernhard Homey,Glennda Smithson,Timothy R. D. J. Radstake,Joël A. G. van Roon	47
14	Salivary Gland Pathology in Sjögren's Syndrome 2016 ·Rheumatic Disease Clinics of North America ·Joana Campos,Maarten R. Hillen,Francesca Barone	28
15	Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis 2016 ·Scandinavian Journal of Rheumatology ·Maarten R. Hillen,(unknown),(unknown),TRDJ Radstake,C. Erik Hack,(unknown),(unknown)	12
16	Thymic stromal lymphopoietin as a novel mediator amplifying immunopathology in rheumatic disease: Fig. 1 2015 ·Lara D. Veeken ·Maarten R. Hillen,Timothy R. D. J. Radstake,Cornelis E. Hack,Joël A. G. van Roon	7
17	The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade 2015 ·PLoS ONE ·Maarten R. Hillen,Sarita A. Y. Hartgring,Cynthia R. Willis,Timothy R. D. J. Radstake,Cornelis E. Hack,Floris P. J. G. Lafeber,Joël A. G. van Roon	6
18	Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren’s syndrome is associated with increased disease activity 2015 ·Modern Rheumatology ·Maarten R. Hillen,Aike A. Kruize,A. Bikker,(unknown),Timothy R. D. J. Radstake,Cornelis E. Hack,Floris P. J. G. Lafeber,Joël A. G. van Roon	9
19	OP0260 Targeting CD1C-Expressing MDCS to Inhibit T Cell Activation and Thymus and Activation Regulated Chemokine (TARC)-Dependent Chemotaxis in RA 2013 ·Annals of the Rheumatic Diseases ·Maarten R. Hillen,(unknown),F.P. Lafeber,C. Erik Hack,(unknown),J.A. van Roon	2
20	Decreased expression of TSLP in labial salivary glands of patients with primary Sjögren’s syndrome is associated with local- and systemic disease parameters 2012 ·Journal of Translational Medicine ·Maarten R. Hillen,A. Bikker,Aike A. Kruize,(unknown),Floris P. J. G. Lafeber,C. Erik Hack,Timothy R. D. J. Radstake,J.A. van Roon	1

About Maarten R. Hillen

Maarten R. Hillen is a scholar working on Physiology, Immunology and Allergy and Immunology, having authored 27 papers that have together received 434 indexed citations. Recurring topics across this work include Salivary Gland Disorders and Functions (22 papers), Systemic Lupus Erythematosus Research (5 papers) and Dermatology and Skin Diseases (4 papers). The work is most often cited by research in Physiology (267 citations), Immunology (156 citations) and Rheumatology (91 citations). Maarten R. Hillen has collaborated with scholars based in Netherlands, Italy and United States. Frequent co-authors include Aike A. Kruize, Joël A. G. van Roon, Timothy R. D. J. Radstake, Sofie L. M. Blokland, Aridaman Pandit, J.A. van Roon, Francesca Barone, Ana P. Lopes, Cornelis P. J. Bekker and Marzia Rossato. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact